IFP Advisors
LENZ icon

IFP Advisors’s LENZ Therapeutics LENZ Stock Holding History

IFP Advisors’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$54 Sell
14
-378
-96% -$1.88K ﹤0.01% 5052
2026
Q2 		$2.23K Buy
392
+375
+2,206% +$3.02K ﹤0.01% 4190
2026
Q1 		$156 Buy
+17
New +$239 ﹤0.01% 4662
2025
Q2 		– Hold
0
– – – 4654
2024
Q4 		– Hold
0
– – – 4392

Other funds holding LENZ

KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Harbor Capital Advisors
Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return
Indivisible Partners
Indivisible Partners Clearwater, Florida $2.18B AUM 33.61% 1-Year Est. Return
Pinnacle Wealth Planning Services
Pinnacle Wealth Planning Services Mansfield, Ohio $1.03B AUM 22.32% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
GF Fund Management
GF Fund Management Guangzhou, China $7.72B AUM 122.96% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

IFP Advisors's LENZ Position: Q3 2026 in Review

IFP Advisors reduced its LENZ Therapeutics (LENZ) stake by 96% in Q3 2026, selling an estimated $1.88K and leaving 14 shares worth $54. The position accounts for ﹤0.01% of the portfolio, ranked #5052.

IFP Advisors first reported a position in LENZ in Q1 2026 and has held it in 3 quarters since. The position peaked at $2.23K in Q2 2026. 21 funds tracked by Wall St. Rank hold LENZ as of Q3 2026.

  • IFP Advisors held 14 shares of LENZ Therapeutics worth $54 as of Q3 2026.
  • IFP Advisors sold 378 LENZ Therapeutics shares in Q3 2026, an estimated $1.88K.
  • LENZ Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #5052 holding.
  • IFP Advisors first reported a position in LENZ Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • IFP Advisors's LENZ Therapeutics position peaked at $2.23K in Q2 2026.
  • 21 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.